Leerink Swann Equities Analysts Increase Earnings Estimates for LifePoint Health Inc (LPNT)

LifePoint Health Inc (NASDAQ:LPNT) – Equities researchers at Leerink Swann upped their FY2018 earnings estimates for LifePoint Health in a note issued to investors on Monday, Zacks Investment Research reports. Leerink Swann analyst A. Gupte now anticipates that the company will post earnings of $4.36 per share for the year, up from their previous forecast of $3.85. Leerink Swann currently has a “Market Perform” rating and a $58.00 target price on the stock. Leerink Swann also issued estimates for LifePoint Health’s FY2019 earnings at $5.00 EPS.

Other equities analysts also recently issued research reports about the stock. BidaskClub raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Thursday, January 11th. Morgan Stanley reaffirmed an “equal weight” rating and set a $46.00 price target (down previously from $50.00) on shares of LifePoint Health in a report on Monday, February 26th. ValuEngine downgraded shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. William Blair reaffirmed an “outperform” rating on shares of LifePoint Health in a report on Tuesday, November 21st. Finally, Royal Bank of Canada lowered their price target on shares of LifePoint Health to $58.00 and set an “outperform” rating on the stock in a report on Monday, February 26th. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $55.00.

LifePoint Health (NASDAQ LPNT) traded up $0.15 on Wednesday, hitting $47.30. 364,765 shares of the company were exchanged, compared to its average volume of 632,624. The company has a debt-to-equity ratio of 1.26, a quick ratio of 1.49 and a current ratio of 1.70. LifePoint Health has a one year low of $41.45 and a one year high of $67.95. The stock has a market capitalization of $1,860.00, a P/E ratio of 23.65, a price-to-earnings-growth ratio of 1.36 and a beta of 0.57.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.04). The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.58 billion. LifePoint Health had a return on equity of 6.34% and a net margin of 1.46%. The business’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.07 EPS.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Cerebellum GP LLC bought a new stake in LifePoint Health in the fourth quarter worth $126,000. State of Alaska Department of Revenue bought a new stake in LifePoint Health in the fourth quarter worth $134,000. US Bancorp DE increased its position in LifePoint Health by 62.4% in the fourth quarter. US Bancorp DE now owns 3,095 shares of the company’s stock worth $155,000 after purchasing an additional 1,189 shares during the last quarter. Xact Kapitalforvaltning AB bought a new stake in LifePoint Health in the fourth quarter worth $230,000. Finally, OxFORD Asset Management LLP bought a new stake in LifePoint Health in the third quarter worth $303,000.

In related news, insider David M. Dill sold 45,000 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total value of $2,183,400.00. Following the sale, the insider now owns 252,673 shares in the company, valued at $12,259,693.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman William F. Carpenter III purchased 21,368 shares of LifePoint Health stock in a transaction that occurred on Wednesday, February 28th. The stock was acquired at an average price of $46.80 per share, for a total transaction of $1,000,022.40. Following the transaction, the chairman now directly owns 482,668 shares of the company’s stock, valued at approximately $22,588,862.40. The disclosure for this purchase can be found here. Company insiders own 8.76% of the company’s stock.

WARNING: This story was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this story on another domain, it was stolen and reposted in violation of United States & international copyright law. The original version of this story can be accessed at https://stocknewstimes.com/2018/03/14/fy2018-earnings-forecast-for-lifepoint-health-inc-issued-by-leerink-swann-lpnt.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply